COMMUNIQUÉS West-GlobeNewswire

Corza Medical Named to the 2024 MedTech Big 100 List
18/09/2024
WESTWOOD, Mass., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Corza Medical (“Corza” or the “Company”), a leading global medical technology company committed to remarkable service, trusted performance and outstanding value, is [...]
Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender Offer
18/09/2024
- Transaction Will Maximize the Access and Uptake of COSELA ® (trilaciclib), the First and Only Proactive Multilineage Myeloprotection Agent - - G1 Stockholders to Receive U.S. $7.15 Per Share in Cash - HOLBAEK, Denmark [...]
Notice of Annual General Meeting 2024
18/09/2024
ANNOUNCEMENT NO. 275 18 September 2024 Notice of Annual General Meeting Notice is hereby given of the Annual General Meeting, which will be held on Thursday 10 October 2024 at 5.30 p.m. The general meeting will be held [...]
Revolo Announces New Preclinical Data Further Validating Atopic Dermatitis as a Target Indication for ‘1104
18/09/2024
Data continues to differentiate ‘1104 as a potential allergic disease treatment that acts upstream in the immune cascade ‘1104 reduces key indices of skin inflammation and inflammatory mediators in a chronic allergen- [...]
Ketabon To Present Advancements In At-Home Ketamine Therapy For Treatment-Resistant Depression At ECNP Congress 2024
18/09/2024
Presentations Will Highlight Oral Prolonged-Release Ketamine (KET01) And its Minimal Impact on Sleep, Alongside Excellent Day-One Tolerability in Patients MUNICH, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ketabon GmbH (“ [...]
Sonnet BioTherapeutics Completes Enrollment in Phase 1 Study of SON-1010 (IL12-FHAB) as a Monotherapy (SB101) for the Treatment of Solid Tumors
18/09/2024
SON-1010 is a targeted immune activation cancer therapy designed to turn ‘cold’ tumors ‘hot’ Topline safety data of SB101 Phase 1 study expected by Q4 2024 PRINCETON, NJ, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Sonnet [...]
Ori Biotech and Charles River Laboratories Collaborate to Accelerate Life-Saving Cell and Gene Therapy Development and Manufacturing
18/09/2024
New Biological Data Released from IRO® Cell Therapy Manufacturing Platform PHILADELPHIA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ori Biotech (Ori), a leader in cell and gene therapy (CGT) manufacturing enabling technology, [...]
Femasys Announces Infertility Clinic Customers from Coast to Coast
18/09/2024
Leading medical clinics become key regional resources to offer FemaSeed infertility treatment ATLANTA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing [...]
BioCardia Regains Full Compliance with Nasdaq Listing Requirements
18/09/2024
SUNNYVALE, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today [...]
Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds
18/09/2024
ROCHESTER, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative [...]
Procaps Issues Shareholder Letter Update
18/09/2024
MIAMI and BARRANQUILLA, Colombia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services, today issued the [...]
Kairos Pharma Closing of $6.2 Million Initial Public Offering
17/09/2024
LOS ANGELES, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Kairos Pharma, Ltd. (“Kairos Pharma” or the “Company”) (NYSE American: KAPA), a clinical stage biopharmaceutical company developing cancer therapeutics designed to reverse [...]
Independent Directors of 23andMe Resign from Board
17/09/2024
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) -- The independent directors of the Board of 23andMe Holding Co. (Nasdaq: ME), today sent the following letter to Anne Wojcicki, Chief Executive Officer, Co- [...]
Traws Pharma, Inc. Announces Special Shareholders Meeting Results
17/09/2024
Three proposals, including a reverse stock split, were submitted and approved Traws Board subsequently approved a 1-for-25 reverse stock split Traws’ shares expected to begin trading on a split-adjusted basis on [...]
Jushi Holdings Inc. Announces Options Issued to Executive Officers
17/09/2024
BOCA RATON, Fla., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) ( OTCQX: JUSHF ), a vertically integrated, multi-state cannabis operator, is pleased to announce that [...]
RadNet, Inc. to Present at the Sidoti & Company Small Cap 2024 Virtual Conference on Wednesday, September 18th
17/09/2024
LOS ANGELES, Sept. 17, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]
Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. as Chief Development Officer
17/09/2024
SAN FRANCISCO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and [...]
Fairway Consulting Group Appoints Brennan Clark as Vice President of Executive Search
17/09/2024
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Fairway Consulting Group (FCG) , a leading executive search firm focused on providing outstanding talent solutions for the pharmaceutical, biotechnology, diagnostic, and [...]
Move Health Holdings Corp. and No Fear Counselling Corp. Complete Merger Transaction
17/09/2024
VANCOUVER, British Columbia and TORONTO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Move Health Holdings Corp . (“Move Health”) and No Fear Counselling Corp . (“No Fear Counselling”), two of Canada’s foremost health and [...]

Pages